Idzerda Leanne, Rader Tamara, Tugwell Peter, Boers Maarten
From the Centre for Global Health Research, Institute of Population Health, University of Ottawa; Department of Medicine, University of Ottawa, Ottawa, Canada; and Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
J Rheumatol. 2014 May;41(5):986-93. doi: 10.3899/jrheum.131308. Epub 2014 Mar 1.
The usefulness of randomized control trials to advance clinical care depends upon the outcomes reported, but disagreement on the choice of outcome measures has resulted in inconsistency and the potential for reporting bias. One solution to this problem is the development of a core outcome set: a minimum set of outcome measures deemed critical for clinical decision making. Within rheumatology the Outcome Measures in Rheumatology (OMERACT) initiative has pioneered the development of core outcome sets since 1992. As the number of diseases addressed by OMERACT has increased and its experience in formulating core sets has grown, clarification and update of the conceptual framework and formulation of a more explicit process of area/domain core set development has become necessary. As part of the update process of the OMERACT Filter criteria to version 2, a literature review was undertaken to compare and contrast the OMERACT conceptual framework with others within and outside rheumatology.
A scoping search was undertaken to examine the extent, range, and nature of conceptual frameworks for core set outcome selection in health. We searched the following resources: Cochrane Library Methods Group Register; Medline; Embase; PsycInfo; Environmental Studies and Policy Collection; and ABI/INFORM Global. We also conducted a targeted Google search.
Five conceptual frameworks were identified: the WHO tripartite definition of health; the 5 Ds (discomfort, disability, drug toxicity, dollar cost, and death); the International Classification of Functioning (ICF); PROMIS (Patient-Reported Outcomes Measurement System); and the Outcomes Hierarchy. Of these, only the 5 Ds and ICF frameworks have been systematically applied in core set development. Outside the area of rheumatology, several core sets were identified; these had been developed through a limited range of consensus-based methods with varying degrees of methodological rigor. None applied a framework to ensure content validity of the end product.
This scoping review reinforced the need for clear methods and standards for core set development. Based on these findings, OMERACT will make its own conceptual framework and working process more explicit. Proposals for how to achieve this were discussed at the OMERACT 11 conference.
随机对照试验对推进临床医疗的效用取决于所报告的结果,但在结果测量指标的选择上存在分歧,导致了不一致性以及报告偏倚的可能性。解决这一问题的一个办法是制定核心结局集:即一组被认为对临床决策至关重要的最小化结局测量指标。自1992年以来,风湿病领域的风湿病结局测量(OMERACT)倡议率先开展了核心结局集的制定工作。随着OMERACT所涉及疾病数量的增加以及其制定核心集的经验不断积累,有必要对概念框架进行澄清和更新,并制定一个更明确的领域/范畴核心集开发流程。作为将OMERACT筛选标准更新至第2版过程的一部分,开展了一项文献综述,以比较和对比OMERACT概念框架与风湿病领域内外的其他概念框架。
进行了一项范围界定检索,以考察健康领域核心集结局选择概念框架的范围、广度和性质。我们检索了以下资源:考克兰系统评价方法组注册库;医学索引;荷兰医学文摘;心理学文摘;环境研究与政策文集;以及ABI/INFORM全球数据库。我们还进行了有针对性的谷歌搜索。
确定了五个概念框架:世界卫生组织对健康的三方定义;5D(不适、残疾、药物毒性、成本和死亡);国际功能、残疾和健康分类(ICF);患者报告结局测量系统(PROMIS);以及结局层次结构。其中,只有5D和ICF框架已被系统地应用于核心集的开发。在风湿病领域之外,确定了几个核心集;这些核心集是通过一系列基于共识的方法开发的,方法严谨程度各不相同。没有一个应用框架来确保最终产品的内容效度。
这项范围界定综述强化了对核心集开发明确方法和标准的需求。基于这些发现,OMERACT将使其自身的概念框架和工作流程更加明确。在OMERACT 11会议上讨论了如何实现这一目标的建议。